Christine Collin-Djangone

Topical use of at least one double-stranded rna oligonucleotide (ds rna)

Vectorization of dsRNA by cationic particles and topical use

Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)

Double-stranded RNA oligonucleotides which inhibit tyrosinase expression

Double strand RNA vectorisation with cationic particles and their topical use

VECTORIZATION OF dsRNA BY CATIONIC PARTICLE AND ITS USE ON SKIN MODEL

Vectorisation of dsRNA by cationic particles and their use for the production of a skin model

Double stranded RNA oligonucleotide to inhibit tyrosinase expression

Vectorization of dsRNA by cationic particles and use of same on a skin model

DOUBLE STRANDED RNA OLIGONUCLEOTIDE FOR THE INHIBITION OF TYROSINASE EXPRESSION